Literature DB >> 18543195

[Prevalence of mild cognitive impairment, amnestic-type, in a Colombian population].

E Henao-Arboleda1, D C Aguirre-Acevedo, C Muñoz, D A Pineda, F Lopera.   

Abstract

INTRODUCTION: Mild cognitive impairment (MCI) is a clinical syndrome that presents with memory disorders, normal general cognition, and no compromise of activities of daily living or dementia. Its diagnosis has important clinical implications, since it behaves as a possible predictor of cognitive disorders that would suggest the onset of dementia. Amnestic-type MCI is considered to be a stage prior to Alzheimer-type dementia. The prevalence of MCI varies from 1-29% and the existence of this diagnosis implies a risk of presenting dementia at 12% per year. AIM: To establish the prevalence of amnestic-type MCI in a group of persons over the age of 50 years from the Valle de Aburra. PATIENTS AND METHODS: The sample was made up of 848 participants of both genders, over 50 years old, who lived in the metropolitan area of Medellin and had different socioeconomic and educational levels. Amnestic MCI was diagnosed according to the criteria proposed by the American Academy of Neurology.
RESULTS: Prevalence of amnestic MCI was 9.7%, and was more predominant in males (p = 0.01) than in females. The prevalence was significantly lower in the group with more than 12 years of schooling (p < 0.05), and no significant differences in the prevalence were found in relation to age or economic status.
CONCLUSION: The prevalence of amnestic MCI, 9.7%, found in our study is within the range reported by other researchers.

Entities:  

Mesh:

Year:  2008        PMID: 18543195

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  8 in total

1.  Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Ricardo García-García; Alfonso Escribano-Hernández; Luis García-Ortiz; Ma Victoria Perea-Bartolomé; Manuel A Gómez-Marcos
Journal:  BMC Neurol       Date:  2011-11-17       Impact factor: 2.474

2.  The Memory Alteration Test Discriminates between Cognitively Healthy Status, Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Nilton Custodio; David Lira; Eder Herrera-Perez; Liza Nuñez Del Prado; José Parodi; Erik Guevara-Silva; Sheila Castro-Suarez; Rosa Montesinos; Patricia Cortijo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-08-27

Review 3.  Epidemiology of mild cognitive impairment in Brazil.

Authors:  Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2013 Oct-Dec

4.  Frequency and associated factors of amnestic mild cognitive impairment at four senior citizen clubs in Lima, Peru.

Authors:  Sofía S Sánchez; Jesus Abanto; Arantxa Sanchez-Boluarte; Alicia Boluarte-Carbajal; Danilo Sanchez-Coronel; Nilton Custodio-Capuñay; Frine Samalvides-Cuba
Journal:  Dement Neuropsychol       Date:  2019 Jul-Sep

5.  Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review.

Authors:  Yuan Lu; Chaojie Liu; Dehua Yu; Sally Fawkes; Jia Ma; Min Zhang; Chunbo Li
Journal:  BMC Geriatr       Date:  2021-01-06       Impact factor: 3.921

6.  The prevalence of mild cognitive impairment in Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Fabiana Silva Ribeiro; Ana Carolina Teixeira-Santos; Anja K Leist
Journal:  Aging Ment Health       Date:  2021-11-29       Impact factor: 3.514

7.  Mild cognitive impairment (MCI) and dementia in a sample of adults in the city of Bogotá.

Authors:  Olga Lucia Pedraza; Ana Maria Salazar Montes; Fabio Alexander Sierra; Maria Camila Montalvo; Yolanda Muñoz; Jose Miguel Díaz; Angela Lozano; Cesar Piñeros
Journal:  Dement Neuropsychol       Date:  2017 Jul-Sep

8.  Cognitive Assessment Test: Validation of a Short Cognitive Test for the Detection of Mild Cognitive Disorder.

Authors:  Kelly Estrada-Orozco; Kely Bonilla-Vargas; Francy Cruz; Oscar Mancera; Miguel Ruiz; Laura Alvarez; Rodrigo Pardo; Humberto Arboleda
Journal:  Int J Alzheimers Dis       Date:  2018-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.